Screener
Amneal Pharmaceuticals, Inc. AMRX Specialty — Intellectual property legal development expenses
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Amneal Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept amrx:IntellectualPropertyLegalDevelopmentExpenses.
The source filing: Amneal Pharmaceuticals, Inc.’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 5:19 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001723128-26-000031
| Three Months Ended June 30, 2026 | Affordable Medicines (1) | Specialty | Av KARE | Corporateand Other | Total Company |
|---|---|---|---|---|---|
| Gross profit | 207,229 | 101,030 | 26,249 | — | 334,508 |
| Selling, general and administrative | 42,367 | 40,095 | 16,913 | 49,347 | 148,722 |
| Research and development | 33,023 | 5,994 | — | — | 39,017 |
| Intellectual property legal development expenses | 2,002 | 85 | — | — | 2,087 |
| Acquisition costs | — | — | — | 7,600 | 7,600 |
| Restructuring and other charges | — | — | — | 554 | 554 |
| Charges related to legal matters, net | 8,057 | — | — | — | 8,057 |
| Other operating income | (1,298) | — | — | — | (1,298) |
Item 1. Financial Statements (Unaudited)
FAQ
- What is Amneal Pharmaceuticals, Inc.'s specialty — intellectual property legal development expenses?
- Amneal Pharmaceuticals, Inc. (AMRX) reported specialty — intellectual property legal development expenses of $85K in Q2 2026.
- How has Amneal Pharmaceuticals, Inc.'s specialty — intellectual property legal development expenses changed year-over-year?
- Amneal Pharmaceuticals, Inc.'s specialty — intellectual property legal development expenses increased by 117.9% year-over-year, from $39K to $85K.
- What is the long-term trend for Amneal Pharmaceuticals, Inc.'s specialty — intellectual property legal development expenses?
- Over 3 years (2021 to 2025), Amneal Pharmaceuticals, Inc.'s specialty — intellectual property legal development expenses has grown at a 16.4% compound annual growth rate (CAGR), from $154K to $243K.
- What does specialty — intellectual property legal development expenses mean?
- Costs incurred to secure, maintain, and defend patents and other intellectual property rights associated with the specialty segment's product portfolio. These expenses are essential for protecting market exclusivity and preventing generic competition for branded assets.
Ask your AI about Amneal Pharmaceuticals, Inc.'s specialty — intellectual property legal development expenses.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude